OCEANIC-AF Trial Sunk; Second Renal Denervation Device Approved; Strep-Stroke Link?

— Recent developments of interest in cardiovascular medicine

MedicalToday
Cardio Break over a computer rendering of a heart.

Bayer announced that the phase III OCEANIC-AF study of the was stopped early due to inferior efficacy compared with apixaban (Eliquis) for patients with atrial fibrillation (Afib).

The CDC reported that the age-adjusted prevalence of hypertension climbed to from 2015 to 2018.

helped predict preeclampsia in pregnant women. (Circulation)

Abnormal cardiac findings were highly prevalent in the aftermath of , whether the patient had acute myocardial injury during hospitalization or not. (Pediatrics)

The from Medtronic became the second renal denervation system to be FDA-approved for the treatment of hypertension.

Medtronic also announced that its received the CE Mark for treating Afib.

The FDA granted 510(k) clearance to Arineta's artificial intelligence-powered technology with the Spotlight cardiovascular CT scanners, the company announced.

Over two decades, in low-income middle-age adults, while higher-income peers were more likely to have diabetes and obesity. (Annals of Internal Medicine)

People with low incomes tended to have during a hospitalization for heart failure. (JAMA Network Open)

In transthyretin amyloid cardiomyopathy, tafamidis (Vyndaqel, Vyndamax) attenuated the in a post hoc analysis of the ATTR-ACT trial. (JAMA Cardiology)

Plenty of people in the real world would not meet the TRILUMINATE trial eligibility criteria for . (JACC: Cardiovascular Interventions)

Progression and regression are both possible with in asymptomatic individuals. (Journal of the American College of Cardiology)

A flexible 0.5-mm Pb equivalent x-ray shield blocked a significant amount of during cardiac catheterization. (Circulation: Cardiovascular Interventions)

In valve-sparing aortic root replacement, concomitant leaflet repair and bicuspid valve disease were the only . (Journal of Thoracic and Cardiovascular Surgery)

A case report describing leading to cardiac arrest in a basketball player was backed by ECG and video evidence. (Heart Rhythm Case Reports)

Soccer player collapsed and died during a match in Albania, and his cardiologist attributed this to the player's decision to remove an implantable cardioverter-defibrillator placed for a "serious ventricular arrhythmia." (Daily Mail)

The health benefits of were quantified in a systematic review. (BMC Medicine)

Might thrombogenic play a role in the pathophysiology of ischemic stroke? (Journal of the American Heart Association)

  • author['full_name']

    Nicole Lou is a reporter for , where she covers cardiology news and other developments in medicine.